The novel role of PPAR alpha in the brain: promising target in therapy of Alzheimer's disease and other neurodegenerative disorders

S Wójtowicz, AK Strosznajder, M Jeżyna… - Neurochemical …, 2020 - Springer
Peroxisome proliferator activated receptor alpha (PPAR-α) belongs to the family of ligand-
regulated nuclear receptors (PPARs). These receptors after heterodimerization with retinoid …

Nutritional aspects of depression

UE Lang, C Beglinger, N Schweinfurth… - Cellular Physiology and …, 2015 - karger.com
Several nutrition, food and dietary compounds have been suggested to be involved in the
onset and maintenance of depressive disorders and in the severity of depressive symptoms …

Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) 2018 guidelines for the management of patients …

LN Yatham, SH Kennedy, SV Parikh… - Bipolar …, 2018 - Wiley Online Library
The Canadian Network for Mood and Anxiety Treatments (CANMAT) previously published
treatment guidelines for bipolar disorder in 2005, along with international commentaries and …

Inflammatory signaling mechanisms in bipolar disorder

GH Jones, CM Vecera, OF Pinjari… - Journal of Biomedical …, 2021 - Springer
Bipolar disorder is a decidedly heterogeneous and multifactorial disease, with a high
individual and societal burden. While not all patients display overt markers of elevated …

Comparative efficacy and tolerability of pharmacological treatments for the treatment of acute bipolar depression: a systematic review and network meta-analysis

A Bahji, D Ermacora, C Stephenson… - Journal of affective …, 2020 - Elsevier
Objective We investigated the comparative efficacy and tolerability of pharmacological
treatment strategies for the treatment of acute bipolar depression. Data sources A systematic …

Treatment-resistant bipolar depression: therapeutic trends, challenges and future directions

OH Elsayed, M Ercis, M Pahwa… - … Disease and Treatment, 2022 - Taylor & Francis
Introduction Bipolar disorder (BD) is a chronic mental illness impacting 1–2% of the
population worldwide and causing high rates of functional impairment. Patients with BD …

Anti‐inflammatory agents in the treatment of bipolar depression: a systematic review and meta‐analysis

JD Rosenblat, R Kakar, M Berk, LV Kessing… - Bipolar …, 2016 - Wiley Online Library
Objective Inflammation has been implicated in the risk, pathophysiology, and progression of
mood disorders and, as such, has become a target of interest in the treatment of bipolar …

[HTML][HTML] Treating insulin resistance with metformin as a strategy to improve clinical outcomes in treatment-resistant bipolar depression (the TRIO-BD study): a …

CV Calkin, KNR Chengappa, K Cairns… - The Journal of clinical …, 2022 - psychiatrist.com
Objective: Therapeutic options are limited for treatment-resistant bipolar depression (TRBD).
Insulin resistance (IR) confers increased risk for TRBD. We investigated metformin, an …

Revisiting inflammation in bipolar disorder

GR Fries, C Walss-Bass, ME Bauer… - … Biochemistry and Behavior, 2019 - Elsevier
Bipolar disorder (BD) has been associated with immune changes, and yet their underlying
mechanisms are still not fully understood. Here, we review the current state of the field …

Bipolar disorder and inflammation

JD Rosenblat, RS McIntyre - Psychiatric Clinics, 2016 - psych.theclinics.com
Methods For this narrative clinical overview, the MEDLINE/PubMed, Embase, Google
Scholar and ClinicalTrials. gov databases were searched from inception through June 2015 …